Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial.
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: Ersi Voskaridou, Athanasios Anagnostopoulos, Kostas Konstantopoulos, Eleni Stoupa, Evgenia Spyropoulou, Christos Kiamouris, Evangelos Terpos
Institution: Laiko General Hospital of Athens
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2119498754
